Clinical Trial Update: Zinc Supplementation With Botulinum Toxin for Overactive Bladder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adding zinc supplementation to botulinum toxin therapy for overactive bladder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botulinum toxin (botulinum toxin)
• ZINC (Zinc chloride)

Snippet

Sponsor: Endeavor Health | Conditions: Overactive Bladder (OAB) | Phase 2 | Status: RECRUITING